Published on
06:54 GMT
MSF publishes TB trial costs to challenge lack of drug trial transparency
Médecins Sans Frontières’ TB-Practecal, a phase 2b-3 randomised controlled trial which identified a new treatment regimen for drug resistant tuberculosis (TB), cost €33.9m (£28.95n; $38.54m), with an average cost of €61 460 per patient, the charity has …
Source:
British Medical Journal
-
Neutral
